Antitrust Antitrust

Servier, Krka illicitly carved up European market for perindopril, EU Commission tells court

By Nicholas Hirst
  • 21 Oct 2021 10:40
  • 21 Oct 2021 10:40
Les Laboratoires Servier's patent settlement with generic drugmaker Krka was a horizontal market-sharing agreement banned by the EU treaties, the European Commission told the EU's top court today.
The regulator is at the EU Court of Justice trying to overturn a lower court ruling that largely upheld a 2014 antitrust

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Nicholas Hirst

Chief Correspondent

Nicholas covers EU merger review and antitrust investigations for Mlex in Brussels. He previously wrote about EU affairs for Politico Europe, European Voice and PaRR. After earning an LLM in European law from the College of Europe in Bruges, he spent a year working in the competition practice of a leading competition law firm in Brussels 2009-10. He graduated in modern European languages from Oxford University in 2006.

Discover MLex

Stay on top of global regulatory developments

Latest News